ContractClinical Investigation Agreement • June 10th, 2021
Contract Type FiledJune 10th, 2021CLINICAL INVESTIGATION AGREEMENT FOR THE DRUGS “A Randomized, Dose-finding and Confirmatory, Double-blind, Placebo-controlled, Parallel-group Multicenter Study with a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age with Childhood Absence Epilepsy or Juvenile Absence Epilepsy " BETWEEN Fondazione IRCCS Istituto Neurologico Carlo Besta (hereinafter referred to as “Institution”), with registered office at Milano, via Celoria 11Tax Code no. 01668320151 and VAT no. 04376340156, in the person of the General Manager, dott. Paola Lattuada, who signs this deed by virtue of the delegation of the power of signature conferred by the Board of Directors' Resolution. n. V / 37 of 1/7/2019, domiciled for the office at the aforementioned Institute represented by its Legal Representative AND UCB BIOSCIENCES GMBH, headquartered in Alfred-Nobel-Strasse 10, 40789 Monheim, Germany , V